ID: ALA438165

Max Phase: Preclinical

Molecular Formula: C16H21N3O7

Molecular Weight: 367.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(=O)N[C@H]1/C(=N/OC(=O)Nc2ccccc2)O[C@H](CO)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C16H21N3O7/c1-2-11(21)18-12-14(23)13(22)10(8-20)25-15(12)19-26-16(24)17-9-6-4-3-5-7-9/h3-7,10,12-14,20,22-23H,2,8H2,1H3,(H,17,24)(H,18,21)/b19-15-/t10-,12-,13-,14-/m1/s1

Standard InChI Key:  ADGOMNHDQHIKMZ-ONSJJQRGSA-N

Associated Targets(Human)

N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 10 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Beta-hexosaminidase 11 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 367.36Molecular Weight (Monoisotopic): 367.1380AlogP: -0.44#Rotatable Bonds: 5
Polar Surface Area: 149.71Molecular Species: NEUTRALHBA: 8HBD: 5
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.74CX Basic pKa: CX LogP: -0.31CX LogD: -0.31
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.35Np Likeness Score: -0.04

References

1. Stubbs KA, Balcewich M, Mark BL, Vocadlo DJ..  (2007)  Small molecule inhibitors of a glycoside hydrolase attenuate inducible AmpC-mediated beta-lactam resistance.,  282  (29): [PMID:17439950] [10.1074/jbc.m700084200]

Source